Dolby Laboratories (Dolby Laboratories) Cash And Cash Equivalents : $657 Mil (As of Dec. 2023)

View and export this data going back to 2005. Start your Free Trial

What is Dolby Laboratories Cash And Cash Equivalents?

Dolby Laboratories's quarterly cash and cash equivalents declined from Jun. 2023 ($765.08 Mil) to Sep. 2023 ($745.36 Mil) but then stayed the same from Sep. 2023 ($745.36 Mil) to Dec. 2023 ($656.82 Mil).

Dolby Laboratories's annual cash and cash equivalents declined from Sep. 2021 ($1,225.38 Mil) to Sep. 2022 ($620.13 Mil) but then increased from Sep. 2022 ($620.13 Mil) to Sep. 2023 ($745.36 Mil).

Dolby Laboratories Cash And Cash Equivalents Historical Data

The historical data trend for Dolby Laboratories's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dolby Laboratories Cash And Cash Equivalents Chart

Dolby Laboratories Annual Data

Trend

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Cash And Cash Equivalents

Get a 7-Day Free Trial

797.21

1,071.88

1,225.38

620.13

745.36

Dolby Laboratories Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Cash And Cash Equivalents	Get a 7-Day Free Trial															626.16	688.44	765.08	745.36	656.82

Dolby Laboratories Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Dolby Laboratories (NYSE:DLB) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

Dolby Laboratories Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Dolby Laboratories's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

Dolby Laboratories (Dolby Laboratories) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Business Services » Dolby Laboratories Inc (NYSE:DLB) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

FUO:Germany FUO:Germany

Address

1275 Market Street, San Francisco, CA, USA, 94103-1410

Website

https://www.dolby.com

Dolby Laboratories Inc develops audio and surround sound for cinema, broadcast, home audio systems, in-car entertainment systems, DVD players, games, televisions, and personal computers. The company generates three fourths of its revenue from licensing its technology to consumer electronics manufacturers around the world. The rest of revenue comes from equipment sales to professional producers and audio engineering services.

Executives

Kevin J Yeaman	officer: VP, Chief Financial Officer	C/O DOLBY LABORATORIES, INC., 1275 MARKET STREET, SAN FRANCISCO CA 94103
Mark Andrew Sherman	officer: EVP, GEN. COUN. & SECRTY	DOLBY LABORATORIES, INC., 1275 MARKET STREET, SAN FRANCISCO CA 94103
John D Couling	officer: SVP, Entertainment	C/O DOLBY LABORATORIES, INC., 1275 MARKET STREET, SAN FRANCISCO CA 94103
Todd Pendleton	officer: SVP, Chief Marketing Officer	1275 MARKET STREET, SAN FRANCISCO CA 94103
Emily Rollins	director	C/O DOLBY LABORATORIES, INC., 1275 MARKET STREET, SAN FRANCISCO CA 94103
Anjali Sud	director	C/O VIMEO INC., 555 WEST 18TH STREET, NEW YORK NY 10011
Simon Segars	director	C/O DOLBY LABORATORIES, INC., 1275 MARKET STREET, SAN FRANCISCO CA 94103
Avadis Tevanian	director	DOLBY LABORATORIES INC, 1275 MARKET STREET, SAN FRANCISCO CA 94103
Peter C Gotcher	director
Ryan Nicholson	officer: VP, Corporate Controller	C/O DOLBY LABORATORIES INC., 1275 MARKET STREET, SAN FRANCISCO CA 94103
Shriram Revankar	officer: SVP, Advanced Technology Group	C/O DOLBY LABORATORIES, INC., 1275 MARKET STREET, SAN FRANCISCO CA 94103
Tony A Prophet	director	9 BERNICE STREET, SAN FRANCISCO CA 94103
Robert J Park	officer: SVP & Chief Financial Officer	C/O DOLBY LABORATORIES, INC., 1275 MARKET STREET, SAN FRANCISCO CA 94103
Steven E Forshay	officer: Sr. Vice President, Research	1275 MARKET STREET, SAN FRANCISCO CA 94103
Lewis Chew	officer: EVP, Chief Financial Officer	DOLBY LABORATORIES, INC., 1275 MARKET STREET, SAN FRANCISCO CA 94103